Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,302 papers from all fields of science
Search
Sign In
Create Free Account
Type II Endometrial Adenocarcinoma
Known as:
Type II Endometrial Carcinoma
A classification of primary endometrial adenocarcinomas that refers to clear cell adenocarcinoma, serous adenocarcinoma, and serous endometrial…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Adenocarcinoma Cell with Intracytoplasmic Mucin
Body of uterus
Endometrium
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
EP632 Does resection of normal appearing omentum influence survival in patients with type 2 endometrial carcinoma?
O. Tal
,
O. Elyashiv
,
E. Ben Shem
,
O. Peled
,
T. Levy
International Journal of Gynecological Cancer
2019
Corpus ID: 213671471
Introduction/Background Type 2 endometrial cancer includes aggressive histologic subtypes such as serous, clear cell and…
Expand
2018
2018
Prognostic Factors in Type I and Type II endometrial carcinoma.
M. Esteve
,
M. Puig
,
D. Al-Dali
,
A. Pereda
,
M. Girvent
,
F. Ojeda
2018
Corpus ID: 202802703
2018
2018
The utility of semi-quantitative dynamic contrast-enhanced MR imaging for differentiating type II endometrial carcinoma from type I endometrial carcinoma
T. Kaminou
,
T. Ogawa
2018
Corpus ID: 53994865
Any information contained in this pdf file is automatically generated from digital material submitted to EPOS by third parties in…
Expand
2017
2017
The impact of p53 in predicting clinical outcome of type II endometrial carcinoma: a retrospective analysis
Fusegi Atsushi
,
F. Akiko
,
+5 authors
Miyasaka Naoyuki
2017
Corpus ID: 117206122
2014
2014
EP-1346: Prognosis and survival of women with type II endometrial carcinoma after adjuvant radiotherapy
R. Foerster
,
R. Kluck
,
H. Rief
,
S. Rieken
,
J. Debus
,
K. Lindel
2014
Corpus ID: 76069413
Review
2013
Review
2013
The impact of multimodality treatment on outcomes of patients with type II endometrial carcinoma: A single institution experience.
S. Talukdar
,
M. Jankowski
,
R. Hanna
,
M. Elshaikh
2013
Corpus ID: 80126807
e16552 Background: To determine the impact of different adjuvant treatment modalities on relapse-free (RFS), disease-specific…
Expand
2013
2013
TUMOR INFILTRATING LYMPHOCYTES PREDICT OUTCOME IN TYPE 2 ENDOMETRIAL CARCINOMA.
M. Versluis
,
H. Nijman
,
De Bock
2013
Corpus ID: 78945437
2013
2013
The utility of semi-quantitative dynamic contrast-enhanced MR imaging for differentiating type II endometrial carcinoma from type I endometrial carcinoma.
Takeru Fukunaga
2013
Corpus ID: 79432968
Poster: "ECR 2013 / C-1735 / The utility of semi-quantitative dynamic contrast-enhanced MR imaging for differentiating type II…
Expand
Review
2012
Review
2012
The impact of adjuvant therapy on tumor recurrence and survival of surgically staged patients with type II endometrial carcinoma: A single institution experience
N. Rasool
,
R. Yechieli
,
J. Robbins
,
Chad M. Cogan
,
M. Elshaikh
2012
Corpus ID: 72755227
2010
2010
PATTERN OF FAILURES AND PROGNOSTIC FACTORS IN TYPE 2 ENDOMETRIAL CARCINOMA: A SINGLE INSTITUTION RETROSPECTIVE STUDY
V. Zanfagnin
,
E. Tripodi
,
+5 authors
P. Zola
2010
Corpus ID: 79778021
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE